Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study.

Chen SW, Tsan YT, Chen JD, Hsieh HI, Lee CH, Lin HH, Wang JD, Chen PC; Health Data Analysis in Taiwan Research Group.

Diabetes Care. 2013 Feb;36(2):369-75. doi: 10.2337/dc11-2197. Epub 2012 Oct 5.

2.

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.

Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM, Chan KA.

Hepatology. 2012 May;55(5):1462-72. doi: 10.1002/hep.25509.

PMID:
22135104
3.

Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.

Lin HC, Hsu YT, Kachingwe BH, Hsu CY, Uang YS, Wang LH.

J Clin Pharm Ther. 2014 Aug;39(4):354-60. doi: 10.1111/jcpt.12151. Epub 2014 Mar 24.

PMID:
24661226
4.

The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.

Koro CE, Sowell MO, Stender M, Qizilbash N.

Clin Ther. 2008 Mar;30(3):535-42. doi: 10.1016/j.clinthera.2008.02.008.

PMID:
18405791
5.

A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients?

Kao CH, Sun LM, Chen PC, Lin MC, Liang JA, Muo CH, Chang SN, Sung FC.

Ann Oncol. 2013 Feb;24(2):523-30. doi: 10.1093/annonc/mds472. Epub 2012 Oct 30.

PMID:
23110810
6.
7.
8.

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, Kim PJ, Owens RJ, Lang NP.

J Clin Oncol. 2007 Apr 20;25(12):1476-81.

PMID:
17442990
9.

Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study.

Tseng YH, Tsan YT, Chan WC, Sheu WH, Chen PC.

Diabetes Care. 2015 Nov;38(11):2068-74. doi: 10.2337/dc15-0563. Epub 2015 Aug 25.

PMID:
26307605
10.

Use of thiazolidinediones and risk of hip fracture in old people in a case-control study in Taiwan.

Lin HF, Liao KF, Chang CM, Lin CL, Lin CH, Lai SW.

Medicine (Baltimore). 2017 Sep;96(36):e7712. doi: 10.1097/MD.0000000000007712.

11.

Thiazolidinediones and fractures: evidence from translating research into action for diabetes.

Bilik D, McEwen LN, Brown MB, Pomeroy NE, Kim C, Asao K, Crosson JC, Duru OK, Ferrara A, Hsiao VC, Karter AJ, Lee PG, Marrero DG, Selby JV, Subramanian U, Herman WH.

J Clin Endocrinol Metab. 2010 Oct;95(10):4560-5. doi: 10.1210/jc.2009-2638. Epub 2010 Jul 14.

12.

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes.

Chao TF, Leu HB, Huang CC, Chen JW, Chan WL, Lin SJ, Chen SA.

Int J Cardiol. 2012 Apr 19;156(2):199-202. doi: 10.1016/j.ijcard.2011.08.081. Epub 2011 Sep 17.

PMID:
21930315
13.

Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus.

Filion KB, Joseph L, Boivin JF, Suissa S, Brophy JM.

Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):785-96. doi: 10.1002/pds.2165. Epub 2011 Jun 13.

PMID:
21671441
14.

Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.

Lu CJ, Sun Y, Muo CH, Chen RC, Chen PC, Hsu CY.

Cerebrovasc Dis. 2013;36(2):145-51. doi: 10.1159/000353679. Epub 2013 Sep 11.

PMID:
24029780
15.

Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.

Azoulay L, Schneider-Lindner V, Dell'aniello S, Filion KB, Suissa S.

Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):343-50. doi: 10.1002/pds.1883.

PMID:
19998318
16.
17.

Thiazolidinediones and PPARγ agonists: time for a reassessment.

Cariou B, Charbonnel B, Staels B.

Trends Endocrinol Metab. 2012 May;23(5):205-15. doi: 10.1016/j.tem.2012.03.001. Epub 2012 Apr 17. Review.

PMID:
22513163
18.

Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

Bazelier MT, Gallagher AM, van Staa TP, Cooper C, Leufkens HG, Vestergaard P, de Vries F.

Pharmacoepidemiol Drug Saf. 2012 May;21(5):507-14. doi: 10.1002/pds.3234. Epub 2012 Mar 6.

PMID:
22392882
19.

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

Aquilante CL, Zhang W, McCollum M.

Curr Med Res Opin. 2007 Mar;23(3):489-94.

PMID:
17355730
20.

A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus.

Seufert J, Lübben G, Dietrich K, Bates PC.

Clin Ther. 2004 Jun;26(6):805-18. Review.

PMID:
15262452

Supplemental Content

Support Center